2 total views
According to the World Health Organisation (WHO), the AstraZeneca COVID-19 vaccine has been temporarily halted by several European Union (EU) countries as a precautionary step.
According to the study, the countries halted the vaccines due to evidence of unusual blood coagulation problems in people who had acquired the vaccine.
The health organisation that approved the vaccine stated that after considering the same facts, several EU countries agreed to continue using the vaccine.
WHO explained that it has considered the benefits of the AstraZeneca vaccine and it outweighed its risks.
“Vaccination against COVID-19 will not reduce illness or deaths from other causes. Thromboembolic events are known to occur frequently. Venous thromboembolism is the third most common cardiovascular disease globally.
“In extensive vaccination campaigns, it is routine for countries to signal potential adverse events following immunization. This does not necessarily mean that the events are linked to vaccination itself, but it is good practice to investigate them. It also shows that the surveillance system works and that effective controls are in place, the statement said,” it said.
It added that it was carefully assessing the latest available safety data for the AstraZeneca vaccine and will immediately communicate the findings to the public.